Robinson T, Escara-Wilke J, Dai J, Zimmermann J, et al. A CXCR4 inhibitor (balixafortide) enhances docetaxel-mediated antitumor activity in a murine model of prostate cancer bone metastasis. Prostate 2023 May 27. doi: 10.1002/pros.24584.
PMID: 37244751